Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-05-13
2008-05-13
Kosar, Andrew D. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S006900, C530S300000, C530S327000, C530S333000
Reexamination Certificate
active
07371728
ABSTRACT:
This invention provides a novel probe, which contains a prostate peptide substrate. The probe can be used as a prostate diagnostic agent for optical imaging. An 11 amino acid peptide substrate is synthesized for specific prostate-specific antigen (PSA). This protected graft copolymer (PGC) consists of a poly-L-lysine (PL) backbone and methoxypoly(ethylene glycol) (MPEG). Two terminals of peptide substrate are bound to poly-L-lysine and Cy5.5 fluorochrome. This probe will be used as a NIR (near-infrared fluorescence) probe for optical imaging.
REFERENCES:
patent: WO 00/04391 (2000-01-01), None
Chao Wei-Hsan
Hsu Jui-Sheng
Liu Gin-Chung
Wang Yun-Ming
Kaohsiung Medical University
Kosar Andrew D.
Volpe and Koenig P.C.
LandOfFree
Prostate-specific antigen probes for optical imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostate-specific antigen probes for optical imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate-specific antigen probes for optical imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2772327